臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 231-255 / 1137 (共46页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-09T05:25:27Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients	ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-09-02T00:08:47Z	Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning	Wang Y.-W;Chen C.-J;Huang H.-C;Wang T.-C;Chen H.-M;Shih J.-Y;Chen J.-S;Huang Y.-S;Chang Y.-C;Chang R.-F.; Wang Y.-W; Chen C.-J; Huang H.-C; Wang T.-C; Chen H.-M; Shih J.-Y; Chen J.-S; Huang Y.-S; Chang Y.-C; Chang R.-F.; RUEY-FENG CHANG
臺大學術典藏	2021-09-01T01:54:28Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:26Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:21Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-09-01T01:53:45Z	Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas	Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.; Shih J.-Y.; Wu S.-G.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:47Z	The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases	Chiang Y.; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Lin Z.-Z.; Lan K.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:29:18Z	Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer	Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T05:44:41Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	LUN-CHE CHEN; Shih J.-Y.; Yu C.-J.; Yang C.-Y.
臺大學術典藏	2021-08-31T05:27:02Z	Effects of left atrial strain on functional capacity in chronic severe mitral regurgitation	LI-TAN YANG; Shih J.-Y.; Liu Y.-W.; Li Y.-H.; Tsai L.-M.; Luo C.-Y.; Tsai W.-C.
臺大學術典藏	2021-08-31T05:27:00Z	Predictive value of left atrial deformation on prognosis in severe primary mitral regurgitation	LI-TAN YANG; Liu Y.-W.; Shih J.-Y.; Li Y.-H.; Tsai L.-M.; Luo C.-Y.; Tsai W.-C.
臺大學術典藏	2021-08-31T03:33:46Z	Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation	Keng L.-T.; Chung K.-P.; SHU-YUNG LIN; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-31T03:33:46Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Liao B.-C.; Bai Y.-Y.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang J.
臺大學術典藏	2021-08-31T03:33:45Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2021-08-31T03:33:45Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2021-08-31T03:33:44Z	Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma	Lu H.-H.; SHU-YUNG LIN; Weng R.R.; Juan Y.-H.; Chen Y.-W.; Hou H.-H.; Hung Z.-C.; Oswita G.A.; Huang Y.-J.; Guu S.-Y.; Khoo K.-H.; Shih J.-Y.; Yu C.-J.; Tsai H.-C.
臺大學術典藏	2021-08-24T02:10:12Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; TAO-MIN HUANG; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-24T00:33:36Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	YAO-WEN KUO; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-24T00:33:36Z	Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation	YAO-WEN KUO; Wu S.-G.; Ho C.-C.; Shih J.-Y.
臺大學術典藏	2021-08-24T00:33:35Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; YAO-WEN KUO; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:36Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	CHUNG-YU CHEN; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:33Z	Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer	CHUNG-YU CHEN; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T03:20:33Z	Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer	CHUNG-YU CHEN; Lin J.-W.; Huang J.-W.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:32Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; CHUNG-YU CHEN; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T03:20:31Z	Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression	CHUNG-YU CHEN; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.

显示项目 231-255 / 1137 (共46页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52805548 在线人数 : 592 教育部委托研究计画计画执行:国立台湾大学图书馆